Home Tags Investigational broad-spectrum antiviral

Tag: investigational broad-spectrum antiviral

Remdesivir Benefits Hospitalized Severe COVID-19 Patients

The median time to recovery was 11 days for patients treated with the drug compared with 15 days for those who received the placebo.

What's HOT from Senior Editors